Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Fierce Pharma: It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin
On Thursday, Patients For Affordable Drugs CEO Merith Basey applauded the decision, saying that it “protects an important pathway for bringing lower-cost generic medicines to patients.” “Had the court ruled the other way, generic manufacturers could have faced increased legal risk when following the rules established by Congress and the FDA. That would have meant […]
Press Releases
WASHINGTON, D.C. — Today, the U.S. Supreme Court unanimously ruled in favor of Hikma in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., preserving a critical pathway that allows lower-cost generic drugs to come to market. The case focused on “skinny labeling,” a long-standing process that allows generic manufacturers to seek approval for off-patent uses of medicines while still […]
News and Reports
The Canadian approval has intensified pressure on US regulators to act. Advocacy groups such as Patients for Affordable Drugs have launched campaigns urging the Food and Drug Administration to expedite generic applications for semaglutide. Legislation has been introduced in Congress to limit patent evergreening, but its prospects remain uncertain.
News and Reports
My name is Helen Bell from Fletcher, North Carolina, and I live with the dual challenges of psoriatic arthritis and Crohn’s disease. Because my immune system is particularly aggressive, or “stubborn” as I call it, my clinical management requires a stacked medication regimen. Currently, I am prescribed Methotrexate, Entyvio, and Rinvoq. Together these medications have […]
News and Reports
POLITICO: House Judiciary Tees Up IP Hearing
The House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence and the Internet is scheduled to hold a hearing June 4 to discuss balancing innovation and access for medicines and intellectual property, according to the House Committee Repository. Last week, Patients For Affordable Drugs Now, AARP, and The ERISA Industry Committee wrote to congressional leadership […]
News and Reports
Epoch Times: Your Prescription May Cost Less Than You Think
Still, those fixes depend on patients knowing where to look and having the time and energy to keep looking. Patients for Affordable Drugs Now said that such tools help in the short term but that they do not solve the underlying problem: the price of the drug itself. “Americans know that high drug prices are […]
News and Reports
STAT News: Trump’s drug-pricing deals set to be tested by new product launches
Alyson Bancroft, the director of legislation, policy, and alliances at Patients for Affordable Drugs Now, said the secretiveness of the White House deals makes it impossible to tell which drugs are covered. “At their core, the MFN deals between the administration and pharmaceutical companies are voluntary agreements that lack meaningful implementation or enforcement mechanisms,” Bancroft […]
News and Reports
The Epoch Times: The Loophole Drug Makers Use to Keep Prices High
Bob Parant left his home on Long Island for the first time when he enrolled in college. Always interested in sports, he decided to try out for the football team in his sophomore year. One day, Parant got a message to report to the athletic office. “The coach calls me in and says, ‘You’ve got […]